Works matching IS 03125963 AND DT 2018 AND VI 57 AND IP 8
Results: 13
Correction to: The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis.
- Published in:
- 2018
- By:
- Publication type:
- corrected article
Correction to: Clinical Pharmacokinetic Characteristics of Cebranopadol, a Novel First-in-Class Analgesic.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pharmacokinetic and Pharmacodynamic Modelling to Characterize the Tolerability of Alternative Up-Titration Regimens of Roflumilast in Patients with Chronic Obstructive Pulmonary Disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Correction to: Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Industry Perspective on Standardizing Food-Effect Studies for New Drug Development.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Methods of Estimating Kidney Function for Drug Dosing in Special Populations.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Daclatasvir: A Review of Preclinical and Clinical Pharmacokinetics.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Evaluation of Tobramycin Exposure Predictions in Three Bayesian Forecasting Programmes Compared with Current Clinical Practice in Children and Adults with Cystic Fibrosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug-Drug Interaction Potential.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Population Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I and II Clinical Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article